AIKON Health
Spin-off from a research institute developing a wearable remote monitoring system for heart failure. The company develops a modular, skin‑patch wearable and accompanying digital platform to capture longitudinal vital-sign and hemodynamic data, enable interoperability with hospital/RPM systems, and generate clinically validated digital biomarkers and predictive alerts to support medication titration and reduce hospital readmissions.
Industries
Nr. of Employees
small (1-50)
AIKON Health
Products
Wearable heart failure monitoring device (skin patch)
A modular skin‑patch wearable designed to record thoracic fluid status, hemodynamic parameters, ECG, respiratory and activity/posture data for up to multi‑day wear.
Wearable heart failure monitoring device (skin patch)
A modular skin‑patch wearable designed to record thoracic fluid status, hemodynamic parameters, ECG, respiratory and activity/posture data for up to multi‑day wear.
Services
Cloud-connected service that ingests wearable-derived physiological data, provides clinician-facing dashboards and predictive alerts to support medication titration and post-discharge monitoring.
Execution of development, testing, validation, and data analysis in multi‑partner projects to clinically evaluate wearable monitoring and digital biomarkers.
Cloud-connected service that ingests wearable-derived physiological data, provides clinician-facing dashboards and predictive alerts to support medication titration and post-discharge monitoring.
Execution of development, testing, validation, and data analysis in multi‑partner projects to clinically evaluate wearable monitoring and digital biomarkers.
Expertise Areas
- Personalized heart failure monitoring
- Remote patient monitoring (RPM)
- Wearable sensor development
- Clinical validation of digital biomarkers
Key Technologies
- Wearable skin‑patch sensors
- Dry electrode sensing
- 1-lead ECG
- Thoracic impedance/fluid monitoring
News & Updates
Announcement of OPZuid funding for a consortium project (HeartLinQ) covering development, testing, validation and data analysis for a wearable monitoring device for heart failure.
Press coverage reporting a €1.2M seed round to advance remote heart failure monitoring.
Research institute coverage of the new spin-off and its wearable monitoring solution for heart failure.
Recognition received at a HealthTech investor summit for a pre-seed pitch.
Announcement of OPZuid funding for a consortium project (HeartLinQ) covering development, testing, validation and data analysis for a wearable monitoring device for heart failure.
Press coverage reporting a €1.2M seed round to advance remote heart failure monitoring.
Research institute coverage of the new spin-off and its wearable monitoring solution for heart failure.
Recognition received at a HealthTech investor summit for a pre-seed pitch.